Back to search

Article

Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication

2022-03-07

Abstract excerpt

New therapeutic targets are a valuable resource in the struggle to reduce the morbidity and mortality associated with the COVID-19 pandemic, caused by the SARS-CoV-2 virus. Genome-wide association studies (GWAS) have identified risk loci, but some loci are associated with co-morbidities and are not specific to host-virus interactions. Here, we identify and experimentally validate a link between reduced expression...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e5c2704b-c11f-522b-b852-a15b5611a417
DOI
10.1101/2022.03.06.483172
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replicationDOI 10.1101/2022.03.06.483172
Select a neighboring publication to make it the new centre.